In addition to improving clinical symptoms and signs, they reduce the incidence of opportunistic infections, stabilize viral loads, increase CD4+ T lymphocyte counts, prolong patient survival, and lower mortality rates (62–70, 157, 158). This evidence concerns the gene CD4 and Opportunistic infection.